Market Overview:
The global hyaluronic acid products market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of osteoarthritis, ophthalmic disorders, and dermal fillers applications, and the rising demand for minimally invasive procedures. Based on type, the global hyaluronic acid products market is segmented into single cycle injection products, three cycle injection products, and five cycle injection products. The single cycle injection product segment is expected to account for the largest share of the global hyaluronic acid product market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period from 2018 to 2030. This growth can be attributed to factors such as rising demand for fast-acting treatments and growing preference for minimally invasive procedures over traditional surgical procedures. Based on application, the global hyaluronic acid product market is divided into osteoarthritis applications, ophthalmic disorders applications, dermal fillers applications,,and vesicoureteral reflux (VUR) treatment applications. The osteoarthritis application segment accounted for majority share of this market in 2017 and this trend is projected continue duringthe forecast period from2018to2030 owingtoits high prevalence rate worldwide coupled with increasing awareness about available treatment options among patients suffering from it .
Product Definition:
Hyaluronic acid products are used to help improve the appearance of skin. The products may be used to reduce the appearance of wrinkles and lines, and to improve the overall look and feel of skin.
Single Cycle Injection Products:
Single cycle injection products, also known as single-phase hyaluronic acid are used to increase the viscosity of a hyaluronic acid solution without significantly changing its properties. They are widely used in medical applications such as fillers and implants. The growing demand for minimally invasive surgical procedures is expected to drive the market over the forecast period.
Three Cycle Injection Products:
Three cycle injection products are used in hyaluronic acid based pharmaceuticals. It is a method of adding vitamins, minerals and amino acids to the injected hyaluronic acid. The three-cycle injection product helps in increasing the viscosity of the liquid without any change in its molecular structure which makes it an ideal choice for injectable drugs.
Application Insights:
The osteoarthritis segment dominated the global market in 2017. This can be attributed to the increasing prevalence of this condition and growing awareness among consumers regarding treatment options. According to a study conducted by the Arthritis Foundation, around 54 million people aged over 18 years have arthritis or rheumatic conditions. Hyaluronic acid injections are used for treating osteoarthritis as it helps in reducing pain & inflammation and improving joint mobility & function.
The dermatology segment is expected to witness lucrative growth during the forecast period owing to rising consumer awareness regarding aesthetic treatments along with advancements in technology that has led to improved results with minimal invasive procedures.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players coupled with high awareness levels and availability of advanced products are some factors responsible for its continued dominance over the forecast period. In addition, increasing prevalence of osteoarthritis is expected to drive demand for hyaluronic acid products in North America during the forecast period.
Asia Pacific is anticipated to be one of fastest-growing regional markets during the same period owing to growing geriatric population, which increases susceptibility towards various diseases such as vesicoureteral reflux (VUR), bladder obstruction,.
Growth Factors:
- Increasing demand for minimally invasive and non-invasive cosmetic procedures
- Rising awareness about the benefits of hyaluronic acid products
- Growing popularity of natural and organic skincare products
- Proliferation of online retail channels
- Availability of a wide range of hyaluronic acid products
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyaluronic Acid Products Market Research Report
By Type
Single Cycle Injection Products, Three Cycle Injection Products, Five Cycle Injection Products
By Application
Osteoarthritis, Ophthalmic, Dermal Fillers, Vesicoureteral Reflux
By Companies
Allergan, Anika, Shanghai Jingfeng Pharmaceutical, Ferring, Galderma, Sanofi, Salix, Smith & Nephew, Zimmer, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Hyaluronic Acid Products Market Report Segments:
The global Hyaluronic Acid Products market is segmented on the basis of:
Types
Single Cycle Injection Products, Three Cycle Injection Products, Five Cycle Injection Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Osteoarthritis, Ophthalmic, Dermal Fillers, Vesicoureteral Reflux
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Anika
- Shanghai Jingfeng Pharmaceutical
- Ferring
- Galderma
- Sanofi
- Salix
- Smith & Nephew
- Zimmer
- Allergan
Highlights of The Hyaluronic Acid Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Cycle Injection Products
- Three Cycle Injection Products
- Five Cycle Injection Products
- By Application:
- Osteoarthritis
- Ophthalmic
- Dermal Fillers
- Vesicoureteral Reflux
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyaluronic Acid Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyaluronic acid is a natural molecule that helps keep your skin hydrated. It can be found in many skincare products, including serums, moisturizers, and eye creams.
Some of the key players operating in the hyaluronic acid products market are Allergan, Anika, Shanghai Jingfeng Pharmaceutical, Ferring, Galderma, Sanofi, Salix, Smith & Nephew, Zimmer, Allergan.
The hyaluronic acid products market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyaluronic Acid Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hyaluronic Acid Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hyaluronic Acid Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hyaluronic Acid Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hyaluronic Acid Products Market Size & Forecast, 2020-2028
4.5.1 Hyaluronic Acid Products Market Size and Y-o-Y Growth
4.5.2 Hyaluronic Acid Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Single Cycle Injection Products
5.2.2 Three Cycle Injection Products
5.2.3 Five Cycle Injection Products
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Osteoarthritis
6.2.2 Ophthalmic
6.2.3 Dermal Fillers
6.2.4 Vesicoureteral Reflux
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hyaluronic Acid Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hyaluronic Acid Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Single Cycle Injection Products
9.6.2 Three Cycle Injection Products
9.6.3 Five Cycle Injection Products
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Osteoarthritis
9.10.2 Ophthalmic
9.10.3 Dermal Fillers
9.10.4 Vesicoureteral Reflux
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Single Cycle Injection Products
10.6.2 Three Cycle Injection Products
10.6.3 Five Cycle Injection Products
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Osteoarthritis
10.10.2 Ophthalmic
10.10.3 Dermal Fillers
10.10.4 Vesicoureteral Reflux
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Single Cycle Injection Products
11.6.2 Three Cycle Injection Products
11.6.3 Five Cycle Injection Products
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Osteoarthritis
11.10.2 Ophthalmic
11.10.3 Dermal Fillers
11.10.4 Vesicoureteral Reflux
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Single Cycle Injection Products
12.6.2 Three Cycle Injection Products
12.6.3 Five Cycle Injection Products
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Osteoarthritis
12.10.2 Ophthalmic
12.10.3 Dermal Fillers
12.10.4 Vesicoureteral Reflux
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Single Cycle Injection Products
13.6.2 Three Cycle Injection Products
13.6.3 Five Cycle Injection Products
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Osteoarthritis
13.10.2 Ophthalmic
13.10.3 Dermal Fillers
13.10.4 Vesicoureteral Reflux
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hyaluronic Acid Products Market: Competitive Dashboard
14.2 Global Hyaluronic Acid Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Anika
14.3.3 Shanghai Jingfeng Pharmaceutical
14.3.4 Ferring
14.3.5 Galderma
14.3.6 Sanofi
14.3.7 Salix
14.3.8 Smith & Nephew
14.3.9 Zimmer
14.3.10 Allergan
